[1]
Melnyk, O. 2021. Immunobiological drugs in the treatment of rheumatic diseases. KIDNEYS. 8, 3 (Sep. 2021), 174–188. DOI:https://doi.org/10.22141/2307-1257.8.3.2019.176456.